Cancer Chemotherapy and Pharmacology

Papers
(The H4-Index of Cancer Chemotherapy and Pharmacology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Tumor microenvironment promotes breast cancer chemoresistance128
Disulfiram: a novel repurposed drug for cancer therapy63
Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells49
Involvement of cytochrome P450 enzymes in inflammation and cancer: a review46
Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer33
Reactive oxygen species in cancer: a paradox between pro- and anti-tumour activities32
Artemisinin-type drugs for the treatment of hematological malignancies31
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer31
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer28
Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway25
Aloin alleviates doxorubicin-induced cardiotoxicity in rats by abrogating oxidative stress and pro-inflammatory cytokines25
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors24
Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo24
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway23
The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis23
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Child22
The role of the glutamine transporter ASCT2 in antineoplastic therapy21
Irinotecan-induced intestinal mucositis in mice: a histopathological study20
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug–drug interaction predictions using a PBPK approach20
The role of deubiquitinating enzymes in cancer drug resistance20
0.030841112136841